Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alain Kummer

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Blood|January 5, 2002
Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?Bellinda A Bladergroen, Chris J L M Meijer, Rosita L ten Berge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathwaysAlfons S K de Hooge, Dagmar Berghuis, Susy Justo Santos, et al.
International Journal of Cancer|July 2, 2009
Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcomePieter J A de Koning, Niels Bovenschen, Frank K J Leusink, et al.
Molecular Immunology|May 9, 2007
Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activationMerel C M Strik, Pieter J A de Koning, Monique J Kleijmeer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
The estimation of tumor cell percentage for molecular testing by pathologists is not accurateAlexander J J Smits, J Alain Kummer, Peter C de Bruin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patientsPontus K E Börjesson, Yvonne W S Jauw, Ronald Boellaard, et al.
Blood|December 4, 2004
Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomasJettie J F Muris, Saskia A G M Cillessen, Wim Vos, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 25, 2012
EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinomaAlexander J J Smits, J Alain Kummer, John W J Hinrichs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinomaSander R van Hooff, Frank K J Leusink, Paul Roepman, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Blood|January 5, 2002
Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?Bellinda A Bladergroen, Chris J L M Meijer, Rosita L ten Berge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathwaysAlfons S K de Hooge, Dagmar Berghuis, Susy Justo Santos, et al.
International Journal of Cancer|July 2, 2009
Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcomePieter J A de Koning, Niels Bovenschen, Frank K J Leusink, et al.
Molecular Immunology|May 9, 2007
Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activationMerel C M Strik, Pieter J A de Koning, Monique J Kleijmeer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
The estimation of tumor cell percentage for molecular testing by pathologists is not accurateAlexander J J Smits, J Alain Kummer, Peter C de Bruin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patientsPontus K E Börjesson, Yvonne W S Jauw, Ronald Boellaard, et al.
Blood|December 4, 2004
Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomasJettie J F Muris, Saskia A G M Cillessen, Wim Vos, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 25, 2012
EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinomaAlexander J J Smits, J Alain Kummer, John W J Hinrichs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinomaSander R van Hooff, Frank K J Leusink, Paul Roepman, et al.
Pageof 5